BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37745444)

  • 1. CDK6-mediated endothelial cell cycle acceleration drives arteriovenous malformations in hereditary hemorrhagic telangiectasia.
    Dinakaran S; Zhao H; Tang Y; Wang Z; Ruiz S; Nomura-Kitabayashi A; Blanc L; Faughnan ME; Marambaud P
    bioRxiv; 2023 Sep; ():. PubMed ID: 37745444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced Endothelial Cell Cycle Arrest Prevents Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia.
    Genet G; Genet N; Paila U; Cain SR; Cwiek A; Chavkin NW; Serbulea V; Figueras A; Cerdà P; McDonnell SP; Sankaranarayanan D; Huba M; Nelson EA; Riera-Mestre A; Hirschi KK
    Circulation; 2024 Mar; 149(12):944-962. PubMed ID: 38126211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain arteriovenous malformation in hereditary hemorrhagic telangiectasia: Recent advances in cellular and molecular mechanisms.
    Drapé E; Anquetil T; Larrivée B; Dubrac A
    Front Hum Neurosci; 2022; 16():1006115. PubMed ID: 36504622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of Activin Receptor-Like Kinase 1 in Endothelial Cells Suppresses Development of Arteriovenous Malformations in Mouse Models of Hereditary Hemorrhagic Telangiectasia.
    Hwan Kim Y; Vu PN; Choe SW; Jeon CJ; Arthur HM; Vary CPH; Lee YJ; Oh SP
    Circ Res; 2020 Oct; 127(9):1122-1137. PubMed ID: 32762495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common and distinctive pathogenetic features of arteriovenous malformations in hereditary hemorrhagic telangiectasia 1 and hereditary hemorrhagic telangiectasia 2 animal models--brief report.
    Garrido-Martin EM; Nguyen HL; Cunningham TA; Choe SW; Jiang Z; Arthur HM; Lee YJ; Oh SP
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2232-6. PubMed ID: 25082229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and characteristics of brain arteriovenous malformations in hereditary hemorrhagic telangiectasia: a systematic review and meta-analysis.
    Brinjikji W; Iyer VN; Wood CP; Lanzino G
    J Neurosurg; 2017 Aug; 127(2):302-310. PubMed ID: 27767404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular deficiency of Smad4 causes arteriovenous malformations: a mouse model of Hereditary Hemorrhagic Telangiectasia.
    Crist AM; Lee AR; Patel NR; Westhoff DE; Meadows SM
    Angiogenesis; 2018 May; 21(2):363-380. PubMed ID: 29460088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correcting Smad1/5/8, mTOR, and VEGFR2 treats pathology in hereditary hemorrhagic telangiectasia models.
    Ruiz S; Zhao H; Chandakkar P; Papoin J; Choi H; Nomura-Kitabayashi A; Patel R; Gillen M; Diao L; Chatterjee PK; He M; Al-Abed Y; Wang P; Metz CN; Oh SP; Blanc L; Campagne F; Marambaud P
    J Clin Invest; 2020 Feb; 130(2):942-957. PubMed ID: 31689244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Microphysiological HHT-on-a-Chip Platform Recapitulates Patient Vascular Lesions.
    Fang JS; Hatch CJ; Andrejecsk J; Trigt WV; Juat DJ; Chen YH; Matsumoto S; Lee AP; Hughes CCW
    bioRxiv; 2024 Mar; ():. PubMed ID: 38559155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiopoietin-2 Inhibition Rescues Arteriovenous Malformation in a Smad4 Hereditary Hemorrhagic Telangiectasia Mouse Model.
    Crist AM; Zhou X; Garai J; Lee AR; Thoele J; Ullmer C; Klein C; Zabaleta J; Meadows SM
    Circulation; 2019 Apr; 139(17):2049-2063. PubMed ID: 30744395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An update on preclinical models of hereditary haemorrhagic telangiectasia: Insights into disease mechanisms.
    Arthur HM; Roman BL
    Front Med (Lausanne); 2022; 9():973964. PubMed ID: 36250069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary Haemorrhagic Telangiectasia, an Inherited Vascular Disorder in Need of Improved Evidence-Based Pharmaceutical Interventions.
    Snodgrass RO; Chico TJA; Arthur HM
    Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33513792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits of Treating Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia: A Retrospective Analysis of 14 Patients.
    Woodall MN; Nakaji P; Spetzler RF
    World Neurosurg X; 2019 Jul; 3():100029. PubMed ID: 31225521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localized conditional induction of brain arteriovenous malformations in a mouse model of hereditary hemorrhagic telangiectasia.
    Scherschinski L; Han C; Kim YH; Winkler EA; Catapano JS; Schriber TD; Vajkoczy P; Lawton MT; Oh SP
    Angiogenesis; 2023 Nov; 26(4):493-503. PubMed ID: 37219736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digital Clubbing in Hereditary Hemorrhagic Telangiectasia/Juvenile Polyposis Syndrome.
    Mrzljak A; Popić J; Ožanić Bulić S
    Acta Dermatovenerol Croat; 2021 Apr; 291(1):56-57. PubMed ID: 34477067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical Treatment vs Nonsurgical Treatment for Brain Arteriovenous Malformations in Patients with Hereditary Hemorrhagic Telangiectasia: A Retrospective Multicenter Consortium Study.
    Meybodi AT; Kim H; Nelson J; Hetts SW; Krings T; terBrugge KG; Faughnan ME; Lawton MT;
    Neurosurgery; 2018 Jan; 82(1):35-47. PubMed ID: 28973426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SMAD4 Prevents Flow Induced Arteriovenous Malformations by Inhibiting Casein Kinase 2.
    Ola R; Künzel SH; Zhang F; Genet G; Chakraborty R; Pibouin-Fragner L; Martin K; Sessa W; Dubrac A; Eichmann A
    Circulation; 2018 Nov; 138(21):2379-2394. PubMed ID: 29976569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced responses to angiogenic cues underlie the pathogenesis of hereditary hemorrhagic telangiectasia 2.
    Choi EJ; Kim YH; Choe SW; Tak YG; Garrido-Martin EM; Chang M; Lee YJ; Oh SP
    PLoS One; 2013; 8(5):e63138. PubMed ID: 23675457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arterial endoglin does not protect against arteriovenous malformations.
    Singh E; Redgrave RE; Phillips HM; Arthur HM
    Angiogenesis; 2020 Nov; 23(4):559-566. PubMed ID: 32506200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical presentation and treatment paradigms of brain arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia.
    Gamboa NT; Joyce EJ; Eli I; Park MS; Taussky P; Schmidt RH; McDonald J; Whitehead KJ; Kalani MYS
    J Clin Neurosci; 2018 May; 51():22-28. PubMed ID: 29483005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.